Shingles Vaccination of U.S. Adults Aged 50–59 Years and ≥60 Years Before Recommendations for Use of Recombinant Zoster Vaccine
Peng-Jun Lu, Mei-Chuan Hung, Anup Srivastav, Walter W. Williams, Kathleen Dooling
Topics & Concepts
MedicineVaccinationShinglesYoung adultDemographyNational Health Interview SurveyPediatricsGerontologyEnvironmental healthPopulationImmunologyVirusSociologyHerpesvirus Infections and TreatmentsFacial Nerve Paralysis Treatment and ResearchDermatology and Skin Diseases